Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. - Wikidata - awgldk - TriplyDB

Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.

Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.

http://www.wikidata.org/entity/Q49076970

about

Haemodilution for acute ischaemic stroke Neuroprotection for ischemic stroke: past, present and future Blood viscosity modulates tissue perfusion – sometimes and somewhere Neuroprotection and antioxidants Neuroprotection for stroke: current status and future perspectives Hyperacute therapies for childhood stroke: a case report and review of the literature The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2.High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial.ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2 Albumin reduces blood-brain barrier permeability but does not alter infarct size in a rat model of neonatal stroke.Albumin therapy improves local vascular dynamics in a rat model of primary microvascular thrombosis: a two-photon laser-scanning microscopy study Albumin therapy augments the effect of thrombolysis on local vascular dynamics in a rat model of arteriolar thrombosis: a two-photon laser-scanning microscopy study.In cold blood: intraarteral cold infusions for selective brain cooling in stroke Albumin activates astrocytes and microglia through mitogen-activated protein kinase pathways.Transient cerebral ischemia induces albumin expression in microglia only in the CA1 region of the gerbil hippocampus Blood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion.α-Linolenic acid prevents endoplasmic reticulum stress-mediated apoptosis of stearic acid lipotoxicity on primary rat hepatocytes Haemodilution for acute ischaemic stroke.Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion: a laser speckle contrast flow study Human albumin prevents 6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo.Chinese consensus statement on the evaluation and intervention of collateral circulation for ischemic stroke Protein-protein interaction network and mechanism analysis in ischemic stroke Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insult Volume-targeted therapy of increased intracranial pressure: the Lund concept unifies surgical and non-surgical treatments.Visualizing the cortical microcirculation in patients with stroke Acute treatment with docosahexaenoic acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats.Intensive care management of ischemic stroke.The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis Impaired leptomeningeal collateral flow contributes to the poor outcome following experimental stroke in the Type 2 diabetic mice.Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma.Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes.Effects of calcium-sensing receptors on apoptosis in rat hippocampus during hypoxia/re-oxygenation through the ERK1/2 pathway.Effects of calcium-sensing receptors on apoptosis in rat hippocampus during hypoxia/reoxygenation through the ERK1/2 pathway Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death.Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement.Clinical trials for cytoprotection in stroke.Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-response and therapeutic window.

P2860

Q24194279-E92DE895-F416-487E-9956-15B1A76A0F21 Q24645185-26ADE91A-556A-419E-82E4-2B1F42295145 Q24658045-F0D157F7-D3B9-479F-BDF5-79BAE2EE3413 Q26740098-AFD2D9F4-F503-4078-8858-CFB3796C785A Q26853031-1E7E88A1-C0E7-4BA8-ABC5-BF296D12087C Q30226818-68BBF513-CE83-4D12-90DB-2D6D33E64379 Q30429188-9338B6D3-52F8-4BF6-BFF9-4E4F74E1D980 Q30572344-6C08DCDA-CBD2-4DA1-BC7C-C40384C02A65 Q30826863-A04AA13F-7C19-4047-947E-3FA8F24F4097 Q31117815-FE250697-80C2-44E3-8197-0CA988BE88F5 Q31118233-F8A30A33-B3B1-4260-A97D-429ADC84F2A2 Q33306793-3344CE46-73BD-4B34-8995-C720812D841E Q33322705-983A37B0-5638-415C-8202-998A0C57045C Q33581184-94424CAE-CAFC-46C2-BE1D-AC48289CF49D Q33615352-50E97CC8-F0EB-440E-8D0A-529C2181FEC6 Q33828068-CB57B80E-ADFC-49D7-A536-A2162C347AD7 Q33863549-574D16DD-F985-4F2B-8A8F-288FA7173713 Q33904744-F8A39618-87D9-4977-92EE-8B1521894248 Q33907619-A77AB808-4D29-47EF-80F8-3FCB03C3CD6D Q34332600-5043BC68-CA5E-4093-B48D-2902F1F7A739 Q34345872-D5381BD4-C2B1-469A-B534-C0562F0266B6 Q34522111-9DEB66B2-AC2E-402C-B4C1-A7BC8F93C300 Q34540909-C1EBBD7D-51E3-4218-ACFB-1D2FCA682FBD Q34567563-00305F59-3ED3-4B4D-9924-396D0A03A2B7 Q34792287-FE566BEA-B8F5-4072-81E5-B0A202D90C31 Q35010187-E55DEC63-9AF1-4C00-B9F9-3C397183B7F2 Q35032398-9E7B9957-BCAC-4DE0-BE56-B81837BFBE25 Q35036485-8AF9A92A-954F-41A9-856E-80CD6724FB91 Q35055490-F7DCD030-DF3C-4A32-AEA9-0A6D15A32889 Q35142897-26D14B23-2C86-4FF2-9F30-8605B74E5060 Q35154045-F1EA00B4-DCAD-4C25-9CD5-79BBE01C6910 Q35648103-AB7E94BF-9851-4582-A817-E1A8D0C68BAF Q35760931-8A6FFC35-04EA-4F8C-B080-387DF7772AA9 Q35784963-1AA39412-8CE7-4FF8-A922-220AA2896831 Q35835792-09E6C792-96B7-4252-B756-24D24EE49DF7 Q35855255-B1608C09-7482-4999-A38F-0F56873C295B Q35956863-51F22187-B131-43D4-9197-9564162F206B Q35962710-D35A56FE-7C3F-421E-A96B-81881267BF6E Q36045223-800AE7AA-EA37-44CB-A7B9-CA423EF33042 Q36248866-AE91BA2C-0E74-4B33-A4AD-3158643B1896

P2860

Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.

http://www.wikidata.org/entity/Q49076970

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Human albumin therapy of acute ...... th a broad therapeutic window.

@en

Human albumin therapy of acute ...... th a broad therapeutic window.

@nl

type

label

Human albumin therapy of acute ...... th a broad therapeutic window.

@en

Human albumin therapy of acute ...... th a broad therapeutic window.

@nl

prefLabel

Human albumin therapy of acute ...... th a broad therapeutic window.

@en

Human albumin therapy of acute ...... th a broad therapeutic window.

@nl

P1433

Q49076970-5C878C2C-BDD6-45E6-84CE-AF73053CF60F

P1476

Q49076970-88E03971-3C7A-486C-B922-C1833C84B3F7

P2093

Q49076970-4A0AC192-8EC6-46F9-9FAD-55F5F5CFE150

Q49076970-588E1C72-4EC6-4876-BBB8-56ECB8962E11

Q49076970-7868F565-805E-42FD-A717-F6FF92E75F8A

Q49076970-7C35F547-A6DA-481E-B9D5-69D86B3AE642

Q49076970-BA162ACA-D312-454A-AA71-C55E44855562

P304

Q49076970-8BAE466B-31B6-4484-8BE4-4DB12F91CCAF

P31

Q49076970-9E4E8253-B78B-4ADF-8647-1F582AAC02B4

P356

Q49076970-0855EBDF-EDF9-42CB-912C-BBBC81A76D31

P407

Q49076970-64085733-0840-4272-B29C-0B384F82DCC1

P433

Q49076970-B694F9B8-4FC0-42E9-A8C4-EAB48D5025AF

P478

Q49076970-7C0D7111-82AE-47CA-9BC0-B0F00633EC43

P577

Q49076970-5CCE89F5-5C35-402D-B880-299AB0F36125

P698

Q49076970-0369E1B4-07EC-47D9-8234-9A209CB21BC6

P356

01.STR.32.2.553

P1433

P1476

Human albumin therapy of acute ...... th a broad therapeutic window.

@en

P2093

L Belayev

http://www.w3.org/2001/XMLSchema#string

M D Ginsberg

http://www.w3.org/2001/XMLSchema#string

R Busto

http://www.w3.org/2001/XMLSchema#string

W Zhao

http://www.w3.org/2001/XMLSchema#string

Y Liu

http://www.w3.org/2001/XMLSchema#string

P304

553-560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.STR.32.2.553

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2001-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11157196

http://www.w3.org/2001/XMLSchema#string